131 related articles for article (PubMed ID: 7298269)
1. Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
Reynolds GP; Riederer P
Int Pharmacopsychiatry; 1981; 16(1):30-3. PubMed ID: 7298269
[TBL] [Abstract][Full Text] [Related]
2. Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.
Reynolds GP; Riederer P; Sandler M
J R Soc Med; 1981 Sep; 74(9):649-52. PubMed ID: 7288807
[TBL] [Abstract][Full Text] [Related]
3. Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure response.
Riederer P; Reynolds GP; Jellinger K; Seemann D; Danielczyk W
Mod Probl Pharmacopsychiatry; 1983; 19():154-61. PubMed ID: 6865963
[No Abstract] [Full Text] [Related]
4. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
[No Abstract] [Full Text] [Related]
5. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
[TBL] [Abstract][Full Text] [Related]
6. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
Beckmann H; Moises HW
Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
[No Abstract] [Full Text] [Related]
7. Critical evaluation of measurement of platelet monoamine oxidase in man.
Honecker H; Christ W; Müller-Oerlinghausen B; Coper H
J Clin Chem Clin Biochem; 1976 Sep; 14(9):453-8. PubMed ID: 965902
[TBL] [Abstract][Full Text] [Related]
8. Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation.
Jarman J; Glover V; Sandler M; Turjanski N; Stern G
J Neural Transm Park Dis Dement Sect; 1993; 5(1):1-4. PubMed ID: 8439389
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant efficacy of tranylcypromine isomers: a controlled study.
Moises HW; Beckmann H
J Neural Transm; 1981; 50(2-4):185-92. PubMed ID: 7017068
[TBL] [Abstract][Full Text] [Related]
10. Effects of tranylcypromine stereoisomers on monamine oxidation in man.
Reynolds GP; Rausch WD; Riederer P
Br J Clin Pharmacol; 1980 May; 9(5):521-3. PubMed ID: 7397067
[No Abstract] [Full Text] [Related]
11. Some properties of human platelet monoamine oxidase in iron-deficiency anaemia.
Youdim MB; Grahame-Smith DG; Woods HF
Clin Sci Mol Med; 1976 Jun; 50(6):479-85. PubMed ID: 6185
[TBL] [Abstract][Full Text] [Related]
12. Effect of tranylcypromine stereoisomers on depressive syndromes.
Rüther E; Jungkunz G; Greil W; Zimmer R
Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
[No Abstract] [Full Text] [Related]
13. Experience with tranylcypromine in early Parkinson's disease.
Fahn S; Chouinard S
J Neural Transm Suppl; 1998; 52():49-61. PubMed ID: 9564607
[TBL] [Abstract][Full Text] [Related]
14. [Determination and comparison of the plasma and urine concentrations in men given tranylcypromine stereoisomers].
Lang A; Geissler HE; Mutschler E
Arzneimittelforschung; 1979; 29(1):154-7. PubMed ID: 582109
[TBL] [Abstract][Full Text] [Related]
15. Dose regimen of deprenyl (selegiline) and platelet MAO activities.
Oreland L; Johansson F; Ekstedt J
Acta Neurol Scand Suppl; 1983; 95():87-9. PubMed ID: 6428150
[TBL] [Abstract][Full Text] [Related]
16. Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease.
Zhou G; Miura Y; Shoji H; Yamada S; Matsuishi T
J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):229-31. PubMed ID: 11160474
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
Riederer P; Jellinger K; Danielczyk W; Seemann D; Ulm G; Reynolds GP; Birkmayer W; Koppel H
Adv Neurol; 1983; 37():159-76. PubMed ID: 6407285
[No Abstract] [Full Text] [Related]
18. Relationship between tranylcypromine sulfate dose and monoamine oxidase inhibition.
Grasso RA; Perry PJ; Sherman AD
DICP; 1991 Jan; 25(1):99-100. PubMed ID: 2008794
[No Abstract] [Full Text] [Related]
19. I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
Gargalidis-Moudanos C; Pizzinat N; Javoy-Agid F; Remaury A; Parini A
Neurochem Int; 1997 Jan; 30(1):31-6. PubMed ID: 9116585
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia.
Wyatt RJ; Karoum F; Stoff DM; Kleinman JE; Gillin JC; Jeste DV; Potkin SG
Clin Genet; 1981 May; 19(5):437-42. PubMed ID: 7296934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
